Pharmaceutical compounding rules is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Pharmaceutical compounding rules, summarised from primary sources posts 151–164
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
An honest declaration on pharmaceutical compounding rules: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
I read post #151 twice before replying, because I had assumed the opposite.
Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict and vary by jurisdiction. Generalising from one country's rules to another's is unreliable.
Adding it in case it saves somebody the afternoon it cost me.
Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal use depends on your country's rules, not on where it is sold.
For what it is worth, the same held on the two occasions I checked.
Small methodological point on pharmaceutical compounding rules: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Collapsed as off-topic by two members at trust level 3 or above
Building on post #155 rather than restating it.
Pharmaceutical compounding rules looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
If the premise is wrong, everything after it is decoration.
A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
On post #155 — agreed on the reasoning, with one qualification.
Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a forum summary of it.
I would be glad to be shown a cleaner way of putting this.
Picking up post #159: that is the part I would want checked first.
I changed my mind about pharmaceutical compounding rules after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.
Collapsed as off-topic by two members at trust level 3 or above
The honest answer on pharmaceutical compounding rules is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.
Most people get the first two right and then argue about the fourth.
If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
I have left out the parts I could not verify.
Building on post #160 rather than restating it.
Pharmaceutical compounding rules came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Post #162 put the caveat in the right place and I want to underline it.
Contradicting a claim in this subcategory is most useful when it comes with a link to the primary source and a date of access.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Research-use-only labelling: what it means and what it does not — the long version
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not — the long version Everything below is what sits behind that. A labelling question, and I would like…
|
+150 | 158 | 55k | 14mo |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
|
+50 | 56 | 780 | 8mo |
|
Coming back to: Research-use-only labelling: what it means and what it does not
Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the…
|
+45 | 50 | 39k | 20mo |
|
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. I was wrong about compounding permissions in a thread last…
|
+72 | 77 | 1.5k | 1d |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for personal quantities in a thread last spring…
|
3 | 60k | 12mo |
Related topics — sharing the tags MHRA, EMA, research use only
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the Regulatory category
Research-use-only status, compounding rules, import restrictions, and the primary documents behind them. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
4 | 49k | 4mo | |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. The question about labelling requirements for research chemicals that I actually want…
|
+5 | 9 | 45k | 4mo |
|
Compounds this community declines to help with, and why
Compounds this community declines to help with, and why — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a compound without…
|
+81 | 87 | 35k | 10mo |
|
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
|
2 | 5.8k | 15mo | |
|
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
|
2 | 182 | 21h |